Mikael Dolsten - 27 Feb 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
President R&D
Signature
Susan E. Grant, by power of atty., for Mikael Dolsten
Issuer symbol
PFE
Transactions as of
27 Feb 2024
Transactions value $
$0
Form type
4
Filing time
28 Feb 2024, 17:00:05 UTC
Previous filing
27 Feb 2024
Next filing
29 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +214,880 $0.000000 214,880 27 Feb 2024 Common Stock 214,880 $26.89 Direct F1
transaction PFE Stock Appreciation Rights Award $0 +189,867 $0.000000 189,867 27 Feb 2024 Common Stock 189,867 $26.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.